JAMA Network
About The Study: In this study, a considerable proportion of patients with high-grade serous cancer missed opportunities for risk assessment with genetic testing and for surgical prevention. Given the lack of effective screening and limited treatment options for high-grade serous cancer, eradicating it requires addressing the full spectrum of missed opportunities.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
